Cashu
CollPlant Biotechnologies: Innovating Regenerative Medicine with Plant-Derived Collagen Solutions
about 21 hours ago
Stocks
Health Care
clgn
CollPlant Biotechnologies New
NASDAQ: CLGN
-0.01 (-0.45%)
2.23
USD
At close at Nov 28, 21:42 UTC
Overview
Loading chart...
Key Stats
Market Cap
25.06M
Dividend Yield
0.00%
P/E Ratio
-1.51
EPS
-1.46
Revenue
515.00K
Avg. Volume
27.66K
About
What does CLGN do?
CollPlant Biotechnologies specializes in regenerative and aesthetic medicine, offering products for tissue regeneration and organ production. Their technology relies on plant-based production of collagen type I (rhCollagen).
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.